Article Figures & Tables
Figures
Fig. 1: Mean difference in sleep latency from sleep records of trials analysing the effect of benzodiazepine versus placebo for the treatment of insomnia; 1-7 day treatment (test for homogeneity, p > 0.05).
Fig. 2: Mean difference in total sleep duration from sleep records of trials analysing the effect of benzodiazepine versus placebo for the treatment of insomnia; 1-7 day treatment (test for homogeneity, p > 0.05).
Fig. 3: Odd ratio of trials analysing effect of benzodiazepine versus placebo in terms of total number of adverse events; 3-7 day treatment (test for homogeneity, p > 0.05).
Fig. 4: Mean difference in sleep latency (above) and total sleep duration (below) of trials analysing the effect of benzodiazepine versus zoplicone for the treatment of insomnia; 3-7 day treatment (sleep latency studies test for homogeneity, p > 0.05; sleep duration studies test for homogeneity, p < 0.01).
In this issue
Article tools
Jump to section
Related Articles
Cited By...
- Psychiatric Medication Users by Age and Sex in the United States, 1999-2018
- Advise non-pharmacological therapy as first line treatment for chronic insomnia
- Deprescription des agonistes des recepteurs des benzodiazepines: Lignes directrices de pratique clinique fondees sur les donnees probantes
- Deprescribing benzodiazepine receptor agonists: Evidence-based clinical practice guideline
- Association between sleep disorders and injury: a nationwide population-based retrospective cohort study
- Aller au fond des choses: Role des anticholinergiques et des benzodiazepines dans le declin cognitif et les chutes
- Turning over the rocks: Role of anticholinergics and benzodiazepines in cognitive decline and falls
- Reducing fall risk while managing hypotension, pain, and poor sleep in an 83-year-old woman
- Effectiveness of non-benzodiazepine hypnotics in treatment of adult insomnia: meta-analysis of data submitted to the Food and Drug Administration
- Acceptability of Behavioral Treatments for Insomnia
- Barriers to nonpharmacologic treatments for stress, anxiety, and insomnia: Family physicians' attitudes toward benzodiazepine prescribing
- Magic bullets for insomnia? Patients' use and experiences of newer (Z drugs) versus older (benzodiazepine) hypnotics for sleep problems in primary care
- Diagnosis and treatment of insomnia
- Response
- Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits
- Incidence of Cancer in Individuals Receiving Chronic Zopiclone or Eszopiclone Requires Prospective Study
- What's wrong with prescribing hypnotics?
- Treating insomnia
- Withdrawal of benzodiazepines in elderly long term users does not produce significant adverse effects in the short term
- Educating physicians to reduce benzodiazepine use by elderly patients: a randomized controlled trial
- Insomnia in the Context of Cancer: A Review of a Neglected Problem
- Treatment of primary insomnia
- Treatment of primary insomnia
- Review: benzodiazepines increase sleep duration but also lead to adverse effects in adults with insomnia
- The diagnosis and management of insomnia in clinical practice: a practical evidence-based approach
More in this TOC Section
Similar Articles
Collections
